Radiotherapy planning for glioblastoma based on a tumor growth model: Implications for spatial dose redistribution

Physics in Medicine and Biology

Volumn 59, Issue 3, 2014, Pages 771-789

  Unkelbach, Jan ^a   Menze, Bjoern H ^b,c   Konukoglu, Ender ^a   Dittmann, Florian ^a   Ayache, Nicholas ^b   Shih, Helen A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b INRIA   (France)

^c ETH ZURICH   (Switzerland)

Author keywords

glioblastoma; prescribed dose distribution; radiotherapy; tumor growth modeling

Indexed keywords

DOSE DISTRIBUTIONS; GLIOBLASTOMAS; GROWTH CHARACTERISTIC; INTENSITY-MODULATED RADIOTHERAPY; RADIOTHERAPY PLANNING; RADIOTHERAPY TREATMENT PLANNING; SPATIOTEMPORAL EVOLUTION; TUMOR GROWTH MODELING;

CELLS; CYTOLOGY; IMAGING TECHNIQUES; PARTIAL DIFFERENTIAL EQUATIONS; RADIOTHERAPY;

TUMORS;

BIOLOGICAL MODEL; BRAIN NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; GLIOBLASTOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PATHOLOGY; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE;

BRAIN NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84892702517     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/59/3/771     Document Type: Article

References (36)

1. Becker K P and Yu J 2012 Status quo - standard-of-care medical and radiation therapy for glioblastoma Cancer J. 18 12-19
2. Berger M S and Wilson C B 1999 The Gliomas (Philadelphia, PA: Saunders)
3. Brahme A and Argren A K 1987 Optimal dose distribution for eradication of heterogeneous tumors Acta Oncol. 26 377-85
4. Chan J L, Lee S W, Fraass B A, Normolle D P, Greenberg H S, Junck L R, Gebarski S S and Sandler H M 2002 Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy J. Clin. Oncol. 20 1635-42
5. Coons S W 1999 Anatomy and growth patterns of diffuse gliomas The Gliomas ed M S Berger and C B Wilson (Philadelphia, PA: Saunders) pp 210-25
6. Deasy J O, Blanco A I and Clark V H 2003 CERR: a computational environment for radiotherapy research Med. Phys. 30 979
7. Dionysiou D D, Stamatakos G S, Gintides D, Uzunoglu N and Kyriaki K 2008 Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation Open Biomed. Eng. J. 2 43-51
8. Fitzek M et al 1999 Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial J. Neurosurg. 91 251-60
9. Götz I and Grosu A L 2013 [18F]FET-PET imaging for treatment and response monitoring of radiation therapy in malignant glioma patients - a review Front. Oncol. 3 1-5
10. Grosu A-L, Weber W A, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M and Molls M 2005 L-(methyl-11c) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 63 64-74
11. Harpold H L P, Alvord E C and Swanson K R 2007 The evolution of mathematical modeling of glioma proliferation and invasion J. Neuropathol. Exp. Neurol. 66 1-9
12. Kelly P J, Daumas-Duport C, Kispert D B, Kall B A, Scheithauer B W and Illig J J 1987 Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms J. Neurosurg. 66 865-74
13. Konukoglu E, Clatz O, Bondiau P-Y, Delingette H and Ayache N 2010 Extrapolating glioma invasion margin in brain magnetic resonance images: suggesting new irradiation margins Med. Image Anal. 14 111-25
14. Kristiansen K et al 1981 Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group Cancer 47 649-52
15. Lawrence Y R, Li X A, el Naqa I, Hahn C A, Marks L B, Merchant T E and Dicker A P 2010 Radiation dose-volume effects in the brain Int. J. Radiat. Oncol. Biol. Phys. 76 S20-S27 (Suppl. 3)
16. Matsukado Y et al 1961 The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice J. Neurosurg. 18 636-44
17. McDonald M W, Shu H-K G, Curran W J Jr and Crocker I R 2011 Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma Int. J. Radiat. Oncol. Biol. Phys. 79 130-6
18. Miwa K, Shinoda J, Yano H, Okumura A, Iwama T, Nakashima T and Sakai N 2004 Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study J. Neurol. Neurosurg. Psychiatry 75 1457-62
19. Murray J D 2002 Mathematical Biology: I. An Introduction (Berlin: Springer)
20. Nakagawa K, Aoki Y, Fujimaki T, Tago M, Terahara A, Karasawa K, Sakata K, Sasaki Y, Matsutani M and Akanuma A 1998 High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme Int. J. Radiat. Oncol. Biol. Phys. 1998 1141-9
21. Nelson D F, Diener-West M, Horton J, Chang C H, Schoenfeld D and Nelson J S 1988 Combined modality approach to treatment of malignant gliomas-re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the radiation therapy oncology group and the eastern cooperative oncology group NCI Monogr. 6 279-84
22. Niyazi M et al 2011 FET-PET for malignant glioma treatment planning Radiother. Oncol. 99 44-48
23. Price S J, Jena R, Burnet N G, Hutchinson P J, Dean A F, Pena A, Pickard J D, Carpenter T A and Gillard J H 2006 Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study Am. J. Neuroradiol. 27 1969-74
24. Rockne R, Rockhill J K, Mrugala M, Spence A M, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord E C and Swanson K R 2010 Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach Phys. Med. Biol. 55 3271-85
25. Ruben J D, Dally M, Bailey M, Smith R, McLean C A and Fedele P 2006 Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy Int. J. Radiat. Oncol. Biol. Phys. 65 499-508
26. Selker R G et al 2002 The brain tumor cooperative group NIH trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine Neurosurgery 51 343-57
27. Souhami L et al 2004 Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol Int. J. Radiat. Oncol. Biol. Phys. 60 853-60
28. Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R and Ganslandt O 2004 Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas Neuroimage 23 454-61
29. Swanson K R, Rostomily R C and Alvord E C 2008 A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle Br. J. Cancer 98 113-9
30. Unkelbach J, Menze B, Konukoglu E, Dittmann F, Ayache N and Shih H 2014 Radiotherapy planning for glioblastoma based on a tumor growth model: improving target volume delineation Phys. Med. Biol. 3 747-70
31. Walker M D et al 1978 Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial J. Neurosurg. 49 333-43
32. Walker M D, Strike T A and Sheline G E 1979 An analysis of dose-effect relationship in the radiotherapy of malignant gliomas Int. J. Radiat. Oncol. Biol. Phys. 5 1725-31
33. Wallner K E, Galicich J H, Krol G, Arbit E and Malkin M G 1989 Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma Int. J. Radiat. Oncol. Biol. Phys. 16 1405-9
34. Watanabe M, Tanaka R and Takeda N 1992 Magnetic resonance imaging and histopathology of cerebral gliomas Neuroradiology 34 463-9
35. Webb S, Evenas P M, Swindel W and Deasy J O 1994 A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume Phys. Med. Biol. 39 2091-8
36. Webb S and Nahum A E 1993 A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys. Med. Biol. 38 653-66